User:Douglas P. Boyd, Ph.D./sandbox

Douglas P. Boyd, Ph.D.

Biography

Dr. Boyd has contributed to the fields of imaging technology, accelerator and beam physics, superconducting systems, nuclear physics, and medical physics. Following his graduate studies in nuclear physics at Rutgers, Dr. Boyd continued his research at Bell Labs under a post-doctoral fellowship program. He then moved to Stanford University and was the project leader for the world’s first pion radiotherapy facility. As part of this program he was one of the early developers of fan-beam, Xenon-detector CT scanners. The resulting patents were licensed by Stanford to General Electric, who in turned sublicensed all CT manufacturers in Europe, U.S. and Japan. These patents generated a major royalty stream to Stanford through 1998. In 1976 Dr. Boyd joined the faculty in at UCSF  with the intent to establish a laboratory to develop the next generation of no-motion CT scanners, with emphasis on cardiac imaging. This led to the foundation of Prior of Imatron, Inc., which since 1982 became the leader in development of electron beam Cardiac CT Scanners (EBCT). From 1986 to 2001 when the company was acquired by General Electric, more than 300 EBCT systems were produced and sold worldwide. The use of these scanners for early detection heart disease helped revolutionize the management or coronary artery disease. Dr. Boyd’s team also pioneered in a number of related imaging developments, including the research leading to the first successful explosive detection scanners for airports, for which he was awarded the prestigious Safe Skies award in 1992. This research led to formation Prior to TSS, Dr. Boyd served as a founding director of InVision Technologies, Inc., a company that since 1990 pioneered in the development of modern CT explosive detection systems that are installed at most major airports in the world today. In 2006, realizing that EDS technology had not yet reached its full potential, Dr. Boyd established TeleSecurity Sciences with the objective to automate the threat resolution process. In 2017 Imatrex Inc. was established to continue the work of Imatron Inc. in Medical Imaging and to develop new approaches to image guided cancer therapy.

Education

1968                Rutgers, the State University, New Brunswick, N.J., Ph.D., Physics

1963                University of Rochester, Rochester, N.Y., B.S.., Physics

Employment and Positions

2017-present    Chief Executive Officer, Imatrex Inc., Las Vegas, NV

2016-presnet    Board of Directors Pyrexar Inc. Salt Lake City Utah

2006-present   Chief Executive Officer, TeleSecurity Sciences, Inc., Las Vegas, NV

2001-2004      Chief Scientist, GE-Imatron, S. San Francisco, CA

1996-2002      CEO, Director, Accuimage Diagnostics Inc., S. San Francisco, CA

1990-2004      Board of Directors, Invision Technologies, Inc., Newark, CA

1983-2001      CEO, Chairman, CTO, Imatron Inc, S. San Francisco, CA

1983-2005      Adjunct Professor, Dept. of Radiology, UCSF

1976-1983      Professor (physics), Dept. of Radiology, UCSF

1969-1976      Research Physicist, Department of Physics, Stanford University

1967-1969      Member of Technical Staff, Bell Telephone Labs, Murray Hill, N.J.

Service on Boards of Directors

2004-2015     BSD Medical Inc. (NASDAQ:BSDM)

1999-2008     ITG Inc., the owner of Heartscan imaging centers